SELLAS Life Sciences Group, Inc. — Form D

SELLAS Life Sciences Group, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-22. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Mark J Ahn, Ph.D.DirectorPortland, OR
Stephen S GallikerDirectorPortland, OR
Rudolph A Nisi, M.D.DirectorPortland, OR
Mark J Ahn, Ph.D.Executive OfficerPortland, OR
Ryan A DunlapExecutive OfficerPortland, OR
Brian A Hamilton, M.D., Ph.D.Executive OfficerPortland, OR
Mark W Schwartz, Ph.D.Executive OfficerSan Ramon, CA
Jane Van WasmanDirectorNew York, NY
Angelos M StergiouDirectorNew York, NY
Angelos M StergiouExecutive OfficerNew York, NY
David A ScheinbergDirectorNew York, NY
John T BurnsExecutive OfficerNew York, NY
John Van VarianDirectorNew York, NY
Robert Van NostrandDirectorNew York, NY
Katherine Bach KalinDirectorNew York, NY
Thomas J KnappExecutive OfficerBethesda, MD
Steven A KriegsmanDirectorLos Angeles, CA
Robert L Van NostrandDirectorNew York, NY
John L VarianDirectorNew York, NY
Barbara A WoodExecutive OfficerNew York, NY
Jane M WasmanDirectorNew York, NY
Sanford J HillsbergDirectorLos Angeles, CA
Mary Ann GrayDirectorSan Ramon, CA
Richard L ChinDirectorSan Ramon, CA
Irving M EinhornDirectorSan Ramon, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2024-03-29D$18.4M$18.4M
2020-08-31D$9.2M$9.2M
2016-07-26D$9.1M$9.1M
2016-05-24D$24.0M$24.0M

More